Clinical Trials Logo

Non-Viable Pregnancy clinical trials

View clinical trials related to Non-Viable Pregnancy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05216952 Completed - Missed Abortion Clinical Trials

Ulipristal Acetate for Use in Early Pregnancy Loss

Start date: May 11, 2022
Phase: Phase 2
Study type: Interventional

The investigators will study the feasibility of using 90mg ulipristal acetate, a selective progesterone receptor agonist, as an adjunct to 800mcg vaginal misoprostol for the medical management of early pregnancy loss. Patients will be followed to assess effective treatment of early pregnancy loss, additional interventions needed, side effects, adverse events and patient acceptability.

NCT ID: NCT03877939 Enrolling by invitation - Clinical trials for Non-Viable Pregnancy

Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy

TESTKM
Start date: September 15, 2019
Phase:
Study type: Observational

Ectopic pregnancy (EP) is a pathology that affects 3%-16% of pregnancies in humans, being the main cause of morbidity and maternal mortality in the first trimester of pregnancy worldwide. The relevance of this problem has led to a demand on the scientific community, to obtain specific and early biomarkers in the determination of EP. In this context, the investigator's group has previously confirmed that both kisspeptin 54 and miR-324-3p are specific, selective and precise biomarkers to identify those patients suffering an EP. However, the utility of a diagnostic test using both biomarkers and other related ones in a population with other types of non-viable pregnancies should still be analysed.